Myopic Degeneration and Netra Restoration Therapy

Myopic Degeneration and Netra Restoration Therapy

Myopic degeneration, also called pathologic myopia or myopic macular degeneration, is a vision-threatening condition that can occur in eyes with excessive axial elongation. It is different from ordinary nearsightedness. A person may have high myopia because the eye is long and the prescription is strong, yet not every highly myopic eye has pathologic degeneration. Myopic degeneration refers to structural disease in the back of the eye, especially the retina, retinal pigment epithelium, choroid, sclera, and optic nerve region.

The International Myopia Institute describes pathologic myopia as excessive axial elongation associated with posterior segment structural changes, including posterior staphyloma, myopic maculopathy, and high-myopia-associated optic neuropathy, that may lead to loss of best-corrected visual acuity. The 2021 IMI Pathologic Myopia report also emphasizes that pathologic myopia is distinct from high myopia: high myopia describes the degree of refractive error, while pathologic myopia describes fundus complications such as posterior staphyloma or myopic maculopathy equal to or more severe than diffuse choroidal atrophy.

For patients, this distinction matters. Glasses or contact lenses may correct the optical blur caused by myopia, but they do not necessarily correct the biological vulnerability of an elongated eye. In myopic degeneration, the posterior eye wall may be stretched, the choroid may become thin, the retinal pigment epithelium may lose support, and photoreceptors may become vulnerable to metabolic stress. The condition can produce central blur, distortion, difficulty reading, reduced contrast sensitivity, scotomas, and progressive loss of visual function.

Netra Restoration Therapy, or NRT, is presented at Netra Eye Institute as an integrative, adjunctive, multi-target ophthalmology platform. For myopic degeneration, NRT is designed to support the underlying biological terrain that influences retinal resilience. It does not claim to reverse axial elongation, remove posterior staphyloma, or cure myopic degeneration. Instead, NRT focuses on supporting the living retinal environment: ocular blood flow, choroidal circulation, retinal metabolism, mitochondrial function, neuroprotection, oxidative stress balance, inflammatory regulation, and whole-body factors that influence eye health.

A Comprehensive Therapy Designed to Address the Key Underlying Drivers of Myopic Degeneration

Myopic degeneration is often discussed in structural terms: long eye, thin retina, stretched sclera, choroidal atrophy, lacquer cracks, posterior staphyloma, and macular atrophy. These structural findings are clinically important, but they are not the whole story. Behind the visible retinal changes are biological processes that may influence whether tissue remains stable, becomes stressed, or continues to degenerate.

NRT approaches myopic degeneration as a disorder of both structure and terrain. The structure includes axial elongation, posterior pole stretching, and altered eye-wall biomechanics. The terrain includes the vascular, metabolic, inflammatory, mitochondrial, neurotrophic, and systemic conditions in which the retina must survive.

In myopic degeneration, the retina is not simply damaged because the prescription is high. The posterior segment is exposed to chronic mechanical strain. The choroid can become thinner. The choriocapillaris may show flow impairment. The retinal pigment epithelium may become fragile. Photoreceptors may lose metabolic support. The sclera may undergo extracellular matrix remodeling. Low-grade inflammation and oxidative stress may further reduce tissue resilience. For some patients, these processes may interact over decades.

NRT is designed to support several core drivers relevant to myopic degeneration:

• Ocular blood flow and choroidal perfusion, especially because the outer retina depends on choroidal circulation for oxygen and nutrient exchange.
• Retinal pigment epithelium resilience, because the RPE supports photoreceptors and helps maintain outer retinal metabolism.
• Photoreceptor survival and function, because visual symptoms in myopic degeneration often arise from central retinal tissue stress.
• Mitochondrial energy production, because retinal cells are highly energy-dependent and vulnerable to metabolic failure.
• Oxidative stress reduction, because an elongated, thinned, metabolically stressed retina may be more vulnerable to reactive oxygen species.
• Inflammatory balance, because emerging research describes chronic low-grade inflammation and immune activation as contributors to myopic retinopathy.
• Neurotrophic and neuroprotective support, because the retina is neural tissue and requires survival signaling, cellular repair capacity, and metabolic stability.
• Whole-person terrain support, including vascular health, metabolic balance, sleep, stress physiology, nutrition, and systemic inflammation.

This systems-based model does not criticize conventional ophthalmology. Retinal imaging, refraction, OCT, fundus photography, axial length measurement, widefield imaging, and professional monitoring are essential. The additional question NRT asks is: what can be done to support the biological environment surrounding the stretched, vulnerable, highly myopic retina?

Why Treatment for Myopic Degeneration Should Be Multi-Factorial

Myopic degeneration should be approached as a multifactorial condition because it is not caused by one isolated abnormality. It is the result of interactions among eye shape, tissue biomechanics, choroidal circulation, retinal metabolism, scleral remodeling, oxidative stress, inflammation, and neurovascular function. A narrow single-pathway approach may miss the complex environment in which degeneration develops.

The myopic eye is often longer than normal. As the eye elongates, the posterior pole may stretch and remodel. This can affect the sclera, choroid, retina, optic nerve head, Bruch membrane, and RPE. The retina is also one of the most metabolically active tissues in the body. It needs constant oxygen delivery, mitochondrial energy, nutrient supply, antioxidant defense, and waste removal. When these supports weaken in a structurally stretched eye, retinal vulnerability can increase.

Axial Elongation and Mechanical Stress

The defining structural problem in pathologic myopia is excessive axial elongation. As the eye lengthens, the posterior tissues are exposed to mechanical strain. The sclera, which forms the outer wall of the eye, may thin and remodel. Bruch membrane and the retinal pigment epithelium can be stretched. The choroid may become thinner. The macular region may develop atrophic changes, tractional changes, or vascular complications.

Mechanical stress is important, but it is not independent from biology. Tissue stretched over time must still maintain blood flow, mitochondrial function, extracellular matrix integrity, immune balance, and cellular repair. NRT does not claim to shorten the eye or reverse established posterior staphyloma. It focuses on supporting the tissue environment that remains biologically active within the elongated eye.

RPE Stress, Scleral Remodeling, and Extracellular Matrix Weakness

The sclera is not an inert shell. It is a living connective tissue that undergoes remodeling. Modern myopia research describes alterations in scleral collagen fibers, proteoglycans, extracellular matrix composition, biomechanical stiffness, and tissue thickness during myopia progression. When scleral remodeling reduces mechanical stability, the posterior pole may become more vulnerable to progressive deformation.

From an integrative perspective, scleral remodeling points toward a broader biological question: how do collagen metabolism, inflammation, oxidative stress, nutrient status, and tissue repair capacity influence the eye wall over time? NRT does not present itself as a scleral remodeling cure. However, it places tissue resilience, microcirculation, and whole-body repair capacity within the overall support strategy.

Choroidal Thinning and Reduced Ocular Blood Flow

The choroid is a vascular layer that supplies the outer retina and RPE. In pathologic myopia, choroidal thinning is common and is associated with more severe myopic macular degeneration. OCT and OCT angiography studies have described choriocapillaris alterations, reduced choroidal thickness, and retinal or choroidal perfusion changes in high myopia and myopic macular degeneration.

This is central to the NRT model. A stretched retina with poor microcirculatory support may be less able to resist oxidative stress, metabolic demand, and repair failure. Supporting ocular blood flow is therefore not a cosmetic idea; it is a biological priority in a condition where choroidal support may be compromised.

Retinal Pigment Epithelium Stress and Photoreceptor Vulnerability

The retinal pigment epithelium performs essential support functions for photoreceptors. It helps recycle visual pigments, clear photoreceptor outer segments, regulate nutrient exchange, maintain the outer blood-retinal barrier, and support the metabolic environment of the outer retina. In myopic degeneration, RPE and choroidal atrophy can reduce the support available to photoreceptors.

Photoreceptors are energy-demanding neural cells. They are vulnerable when circulation, RPE function, mitochondrial energy, and antioxidant defense are impaired. A multi-factorial approach should therefore support not only retinal structure, but also the metabolic conditions that photoreceptors require to function.

Oxidative Stress and Microinflammation

High myopia and myopic retinal degeneration are increasingly discussed in relation to oxidative stress and chronic low-grade inflammation. A 2024 review on complications of high myopia noted that excessive elongation of the eyeball can alter the intraocular microenvironment, with increased oxidative stress and microinflammation. A 2025 review focused specifically on inflammation in myopic retinopathy described mechanical stress, hypoperfusion, extracellular matrix remodeling, growth-factor dysregulation, and chronic low-grade inflammation as interacting mechanisms.

This supports the rationale for integrative ophthalmology. Oxidative stress and inflammation are systems-level processes. They can be influenced by local retinal strain, metabolic health, vascular function, immune activity, diet, sleep, environmental exposures, and stress physiology. NRT emphasizes reduction of avoidable biological burden while supporting retinal resilience.

Mitochondrial Vulnerability and Cellular Energy Demand

The retina has extraordinary energy requirements. Even though myopic degeneration is often framed as a structural disease, retinal cells still depend on mitochondrial function to survive chronic stress. When mitochondria are strained, cells may generate more reactive oxygen species, lose repair capacity, and become more vulnerable to degeneration.

Mitochondrial support is therefore relevant to NRT. The goal is not to reduce myopic degeneration to a mitochondrial disease. The goal is to recognize mitochondria as one of the core biological nodes connecting blood flow, oxidative stress, inflammation, and neuroprotection.

Neuroprotection and Retinal Resilience

The retina is part of the central nervous system. Myopic degeneration can affect photoreceptors, inner retinal layers, the optic nerve region, and the neurovascular unit. Neuroprotection refers to supporting neural tissue survival and function under stress. In myopic degeneration, this means supporting photoreceptors, retinal ganglion cells, glia, RPE, and the vascular support network.

NRT uses neuroprotection as a practical clinical concept: reduce biological stress, support circulation, improve cellular energy, regulate inflammation, and support the terrain in which retinal neurons function.

Key Biological Mechanisms in Myopic Degeneration

Posterior Staphyloma and Posterior Pole Deformation

Posterior staphyloma is an outpouching of the posterior eye wall and is one of the hallmark structural changes in pathologic myopia. It can alter the contour of the retina, choroid, sclera, and optic nerve head. The shape of the posterior pole matters because abnormal curvature can create mechanical stress, distort retinal layers, and contribute to macular vulnerability.

NRT should be described honestly in this context. It does not claim to reshape the posterior eye wall. Its role is supportive: helping the tissues within a structurally vulnerable eye maintain better biological resilience wherever possible.

Myopic Maculopathy and Atrophic Progression

The META-PM classification defines a progression of myopic maculopathy from no lesion to tessellated fundus, diffuse chorioretinal atrophy, patchy chorioretinal atrophy, and macular atrophy, with additional plus lesions such as lacquer cracks, myopic choroidal neovascularization, and Fuchs spot. This classification helps clinicians describe the visible severity of myopic degeneration.

For a patient, these categories are not merely labels. They reflect progressive loss of structural support in the retina, RPE, and choroid. NRT focuses on the biological environment that may influence retinal function and resilience within these structural limitations.

Choroidal and Choriocapillaris Insufficiency

The choroid supplies the outer retina. In high myopia, the choroid often becomes thin, and choriocapillaris flow may be altered. Studies have reported that thinner choroid is associated with increased myopic macular degeneration severity. Research using OCT angiography has also identified choriocapillaris changes and reduced vascular density in highly myopic eyes.

This mechanism is one of the strongest reasons to consider ocular blood flow support. If the choroid is thin and perfusion is reduced, the RPE and photoreceptors may face a chronic mismatch between metabolic demand and vascular supply. NRT places choroidal circulation and microvascular support at the center of its approach to myopic degeneration.

Retinal Pigment Epithelium and Bruch Membrane Stress

The RPE and Bruch membrane form a critical support interface between photoreceptors and the choroid. In myopic degeneration, mechanical stretching, choroidal thinning, oxidative stress, and impaired nutrient exchange can strain this interface. Lacquer cracks are thought to reflect breaks in Bruch membrane, and atrophic changes may involve RPE and choroidal tissue loss.

Supporting RPE resilience may involve attention to oxidative stress, mitochondrial function, blood flow, inflammation, nutritional status, and systemic metabolic health. NRT approaches the RPE as a living support tissue, not merely as a layer seen on imaging.

Photoreceptor Degeneration and Visual Function Loss

Photoreceptors convert light into visual signals. In myopic degeneration, photoreceptors may become vulnerable because of stretched retinal architecture, poor RPE support, choroidal insufficiency, oxidative stress, and local inflammation. Damage in the macula can lead to central visual symptoms such as distortion, blur, missing spots, and reduced reading ability.

NRT emphasizes photoreceptor support by targeting the environment that photoreceptors depend on: oxygen delivery, nutrient supply, mitochondrial energy, antioxidant defense, and neuroprotective signaling.

Myopic Traction and Retinal Layer Stress

Some highly myopic eyes develop tractional changes at the macula because the elongated eye, posterior staphyloma, vitreous interface, and retinal layers do not always remodel evenly. This can contribute to foveoschisis, macular traction, lamellar changes, or other structural complications. These are mechanical and anatomical problems that require appropriate professional monitoring.

For the NRT page, the important message is balance. NRT is not positioned as a mechanical repair for tractional pathology. It may be positioned as supportive care for retinal metabolism, circulation, inflammation balance, and neuroprotection in patients whose eyes are structurally vulnerable.

Oxidative Stress and Hypoxia Signaling

Oxidative stress occurs when reactive oxygen species exceed the tissue ability to neutralize them. In a highly myopic eye, reduced choroidal support, tissue stretching, and retinal metabolic demand may increase vulnerability to oxidative injury. Research has also explored the relationship between systemic oxidative stress and myopic choroidal neovascularization, suggesting that oxidative stress may relate to disease activity in highly myopic eyes.

Oxidative injury can affect lipids, proteins, DNA, mitochondria, RPE cells, and photoreceptors. It can also amplify inflammation and vascular stress. NRT addresses oxidative stress as a central biological pathway in retinal support.

Inflammation and Immune Pathways

Inflammation is increasingly recognized in myopic retinal disease. While mechanical stress and hypoperfusion are central, chronic immune activation may contribute to tissue remodeling, vascular dysfunction, extracellular matrix changes, and retinal degeneration. Both local ocular inflammation and systemic inflammatory tone may influence retinal vulnerability.

This is where traditional medical language and modern biology can be bridged carefully. In Traditional Chinese Medicine, terms such as Blood Stasis, Qi Deficiency, Liver Blood Deficiency, Kidney Essence Deficiency, and Yin Deficiency may describe patterns of impaired nourishment, poor circulation, tissue depletion, and chronic degeneration. These are not direct scientific equivalents, but they can be interpreted as traditional frameworks that overlap conceptually with vascular insufficiency, reduced repair capacity, metabolic depletion, and degenerative aging.

Neurotrophic Support: BDNF, NGF, and Neural Resilience

Neurotrophins such as brain-derived neurotrophic factor and nerve growth factor support neural survival, plasticity, and repair. Although myopic degeneration is driven strongly by axial and structural factors, the retina remains neural tissue. Retinal neurons, photoreceptors, glial cells, and the optic nerve region require survival signaling and metabolic support.

NRT includes neurotrophic support as part of a broader neuroprotective model. The page should not imply that NRT has proven direct disease-modifying effects on BDNF or NGF in myopic degeneration. A scientifically balanced statement is that neurotrophin biology provides one rationale for supporting retinal resilience through multi-target integrative care.

What Is Netra Restoration Therapy for Myopic Degeneration?

Netra Restoration Therapy is a full-spectrum, integrative ophthalmology platform designed to support ocular health through multiple biological pathways simultaneously. For myopic degeneration, NRT focuses on supporting the retina, choroid, RPE, photoreceptors, optic nerve region, and systemic terrain that may influence ocular tissue resilience.

Because myopic degeneration includes structural changes, it is important to define NRT responsibly. NRT does not claim to reverse high myopia, shorten axial length, remove posterior staphyloma, erase lacquer cracks, or cure macular atrophy. It is an adjunctive approach designed to support retinal function and the biological environment surrounding vulnerable tissue.

A personalized NRT plan may include integrative strategies directed toward:

• Supporting ocular blood flow and choroidal circulation.
• Improving retinal metabolic support and mitochondrial resilience.
• Reducing oxidative burden and supporting antioxidant defense.
• Supporting inflammatory balance in the eye-body system.
• Supporting retinal neuroprotection and neurotrophic signaling.
• Evaluating systemic contributors such as metabolic dysfunction, vascular health, stress physiology, sleep, and nutritional status.
• Using acupuncture, herbal medicine, Ayurvedic principles, nutrition, and functional medicine concepts in a coordinated, individualized manner.

This multi-target design reflects the complexity of myopic degeneration. A stretched posterior eye wall creates vulnerability, but the living tissue response is shaped by blood flow, inflammation, oxidative stress, mitochondrial function, extracellular matrix biology, and systemic health. NRT aims to support these modifiable biological layers without replacing retinal diagnosis, monitoring, or urgent eye care when symptoms change.

How NRT Supports the Biological Terrain in Myopic Degeneration

Supporting Ocular Blood Flow and Choroidal Circulation

Ocular blood flow is a major focus of NRT because the highly myopic retina often has reduced choroidal thickness and altered choroidal circulation. Research has shown that axial length changes can influence choroidal blood flow, and choriocapillaris alterations are associated with myopic macular degeneration severity. A retina that receives less vascular support may be more vulnerable to hypoxia, oxidative injury, and poor waste clearance.

NRT approaches circulation from both ocular and systemic perspectives. Microcirculation may be influenced by endothelial function, autonomic regulation, blood pressure patterns, metabolic inflammation, vascular stiffness, stress physiology, and general cardiovascular health. The goal is to support the vascular environment that nourishes the retina.

Supporting the Retinal Pigment Epithelium

The RPE is essential for photoreceptor survival. In myopic degeneration, RPE stress and atrophic changes can affect central vision. NRT supports RPE resilience through attention to oxidative stress, mitochondrial energy, nutrient sufficiency, inflammation balance, and choroidal blood flow. The goal is to improve the conditions under which remaining RPE cells function.

Supporting Photoreceptors and Visual Function

Patients with myopic degeneration often experience visual symptoms that reflect photoreceptor stress in the macular region. NRT focuses on supporting photoreceptor resilience through vascular support, mitochondrial support, antioxidant support, and neuroprotection. This does not guarantee visual improvement, but it offers a rational supportive framework for tissue that remains viable.

Supporting Mitochondrial Function

The retinal energy demand is high. Mitochondrial dysfunction can reduce cellular repair, increase reactive oxygen species, and intensify inflammation. NRT supports mitochondrial function through a whole-person model that may include nutritional evaluation, metabolic support, circulatory support, inflammation reduction, sleep optimization, and stress regulation.

Reducing Oxidative Stress Burden

Oxidative stress is relevant in high myopia because the retinal environment can become metabolically strained. NRT may use nutritional, botanical, lifestyle, and metabolic strategies to support antioxidant defenses. Herbal and botanical approaches should be explained through modern systems biology: many herbs contain multiple bioactive compounds that may influence oxidative stress, inflammation, vascular function, mitochondrial pathways, and cellular resilience.

Supporting Inflammatory Balance

Inflammation in myopic degeneration should not be portrayed as a simple infection-like process. It is more often a chronic, low-grade biological response connected with tissue strain, hypoperfusion, oxidative stress, and immune signaling. NRT seeks to support balanced immune function through a combination of nutrition, herbs, acupuncture, stress regulation, sleep support, metabolic assessment, and gut-retina considerations.

Supporting Scleral and Connective Tissue Terrain

Scleral remodeling is a central feature in myopia progression and pathologic myopia. While established structural elongation cannot be reversed by NRT claims, the broader connective tissue environment may still be supported through nutritional sufficiency, inflammation balance, antioxidant defense, and systemic health. This is best framed as supportive terrain care rather than structural correction.

Translating TCM and Ayurveda into Modern Biological Language

Traditional Chinese Medicine may describe degenerative myopic presentations through patterns such as Kidney Essence Deficiency, Liver Blood Deficiency, Spleen Qi Deficiency, Blood Stasis, or Yin Deficiency. In modern interpretive terms, these may loosely correspond to tissue depletion, impaired nourishment, reduced repair capacity, microvascular insufficiency, chronic dryness, neuroendocrine stress, or degenerative aging. These are conceptual parallels rather than exact scientific definitions.

Ayurvedic concepts such as Vata, Pitta, Kapha, Rakta Dhatu, Majja Dhatu, and Ojas may be used as traditional frameworks for nervous system regulation, inflammatory balance, circulation, tissue nourishment, vitality, and resilience. For a modern website, these concepts should be described as interpretive systems that can coexist with biomedical ideas such as ocular perfusion, mitochondrial function, oxidative stress, and retinal neuroprotection.

Understanding Herbal Medicine as Network Pharmacology

Herbal medicine should not be presented merely as folk tradition. Modern research increasingly studies herbs and formulas through network pharmacology, systems biology, transcriptomics, proteomics, metabolomics, and molecular pathway analysis. A single herb can contain many bioactive compounds. A traditional formula can contain hundreds or thousands of phytochemicals. These compounds may influence multiple pathways at once.

For myopic degeneration, the most relevant pathways include oxidative stress, inflammation, microcirculation, mitochondrial function, extracellular matrix biology, endothelial function, and neuroprotection. Evidence varies by herb, formula, and condition. Therefore, the page should avoid claiming that herbs cure myopic degeneration, while still explaining why multi-component botanical interventions are scientifically interesting as systems-level support.

Supporting Whole-Person Terrain

Myopic degeneration occurs in the eye, but the eye exists within the body. Systemic vascular health, metabolic inflammation, sleep, stress physiology, nutrition, digestive health, and oxidative burden may all influence tissue resilience. NRT evaluates the whole patient because the retinal ability to function depends on more than the shape of the eye.

This whole-person approach is especially important for patients who feel that their condition has been reduced to imaging findings alone. NRT adds a biological terrain perspective: what factors can be improved to help the eye function in the best possible internal environment?

Frequently Asked Questions on Myopic Degeneration

Selected References for Scientific Support

• Ohno-Matsui K, Wu PC, Yamashiro K, et al. IMI Pathologic Myopia. Investigative Ophthalmology & Visual Science. 2021;62(5):5. This International Myopia Institute report distinguishes high myopia from pathologic myopia and defines pathologic myopia by posterior segment complications such as posterior staphyloma and myopic maculopathy. https://pmc.ncbi.nlm.nih.gov/articles/PMC8083114/
• Ohno-Matsui K, Kawasaki R, Jonas JB, et al. International photographic classification and grading system for myopic maculopathy. American Journal of Ophthalmology. 2015. The META-PM classification describes categories from no maculopathy to macular atrophy, with plus lesions including lacquer cracks, myopic CNV, and Fuchs spot. https://www.ajo.com/article/S0002-9394(15)00051-3/abstract
• Shi H, Guo N, et al. Global prevalence of myopic macular degeneration in general population and patients with high myopia: a systematic review and meta-analysis. European Journal of Ophthalmology. 2024. This meta-analysis reported pooled MMD prevalence of 1.7% in the general population and 49.0% among patients with high myopia. https://pubmed.ncbi.nlm.nih.gov/37439028/
• Fricke TR, Jong M, Naidoo KS, et al. Global prevalence of visual impairment associated with myopic macular degeneration and temporal trends from 2000 through 2050. British Journal of Ophthalmology. 2018. This study estimated the global burden of visual impairment associated with myopic macular degeneration. https://pmc.ncbi.nlm.nih.gov/articles/PMC6047154/
• Du Y, et al. Complications of high myopia: an update from clinical manifestations to underlying mechanisms. 2024. This review discusses complications of high myopia and describes oxidative stress and microinflammation in the altered high-myopia intraocular microenvironment. https://pmc.ncbi.nlm.nih.gov/articles/PMC11260019/
• Yin X, et al. The Role of Scleral Changes in the Progression of Myopia. 2025. This review summarizes scleral collagen, extracellular matrix, and biomechanical remodeling during myopia progression. https://pmc.ncbi.nlm.nih.gov/articles/PMC12109009/
• Li J, et al. Choriocapillaris Changes in Myopic Macular Degeneration. 2022. This study reports that thinner choroid is associated with increased MMD severity and analyzes choriocapillaris alterations. https://pmc.ncbi.nlm.nih.gov/articles/PMC8883151/
• Yang YS, et al. Choroidal Blood Flow Change in Eyes with High Myopia. 2015. This study found that axial length changes in high myopes may influence choroidal blood flow. https://pmc.ncbi.nlm.nih.gov/articles/PMC4595256/
• Yang T, et al. The role of inflammation in myopic retinopathy. 2025. This review discusses mechanical stress, hypoperfusion, extracellular matrix remodeling, growth factor dysregulation, and chronic low-grade inflammation in myopic retinopathy. https://pmc.ncbi.nlm.nih.gov/articles/PMC12404955/
• Baksh J, et al. A Review from the Perspective of Choroidal Blood Flow. 2024. This review discusses choroidal blood flow in relation to ocular disease and includes pathologic myopia-related evidence. https://pmc.ncbi.nlm.nih.gov/articles/PMC11122110/
• Wang J, et al. Systemic Oxidative Stress Level as a Pathological and Treatment-Response Biomarker in Myopic Choroidal Neovascularization. 2024. This study examines systemic oxidative stress in high myopia and myopic CNV. https://pmc.ncbi.nlm.nih.gov/articles/PMC11293568/
• Li Y, et al. Advances in OCT Imaging in Myopia and Pathologic Myopia. 2022. This review discusses OCT imaging of retinochoroidal structures and complications in pathologic myopia. https://pmc.ncbi.nlm.nih.gov/articles/PMC9221645/
• Leszczynska A, et al. The short-term effect of acupuncture on different ocular blood flow parameters in patients with glaucoma: a randomized, controlled, crossover trial. 2018. This preliminary study reported short-term changes in choroidal blood flow after eye-specific acupuncture, supporting further research into ocular perfusion mechanisms. https://pmc.ncbi.nlm.nih.gov/articles/PMC6055908/
• Yu T, et al. Electroacupuncture Improves Choroidal Blood Flow to Inhibit the Development of Lens-Induced Myopia in Guinea Pigs. 2022. This animal study explored electroacupuncture, choroidal blood flow, and myopia progression; the evidence is preclinical and should not be overstated for human myopic degeneration. https://pmc.ncbi.nlm.nih.gov/articles/PMC9249499/